Institute of Pharmaceutical Sciences

74.2k citations
1.5k papers ·

Impact in

  • Biomaterials top 10%
    • Nanoparticle-Based Drug Delivery
  • Oncology top 10%
    • Lymphatic System and Diseases

Papers in

Institute of Pharmaceutical Sciences

1.4k papers receiving 68.8k citations

Peers

Institute of Pharmaceutical Sciences
Comparison fields: 5 of 216
  • Biomaterials 7.3k
  • Oncology 13.2k
  • Pharmaceutical Science 3.2k
  • Molecular Biology 29.9k
  • Immunology 7.1k
Replace Institut de Biologie et de Chimie des Protéines with:
Institut de Biologie et de Chimie des Protéines France
Institute of Biomedical Technologies Italy
Laboratoire de Biophotonique et Pharmacologie France
Immunologie, Immunopathologie et Chimie Thérapeutique France
Laboratoire des Biomolécules France
Slotervaartziekenhuis Netherlands
Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques France
Institute of Chemistry of Molecular Recognition Italy
UCB Pharma (Belgium) Belgium
Institute for Biomedicine Italy
Institute of Pharmaceutical Sciences relative to Institut de Biologie et de Chimie des Protéines France Institut de Biologie et de Chimie des Protéines's profile →
Citations per field
00.5×1.5×2.1×
Institut de Biologie et de Chimie des Protéines · 1×
Citations per year

Countries citing scholars working at Institute of Pharmaceutical Sciences

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Institute of Pharmaceutical Sciences. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Institute of Pharmaceutical Sciences with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Institute of Pharmaceutical Sciences more than expected).

Fields of papers published by authors at Institute of Pharmaceutical Sciences

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Institute of Pharmaceutical Sciences at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Institute of Pharmaceutical Sciences at the time of their publication.

About Institute of Pharmaceutical Sciences

In recent decades, authors affiliated with Institute of Pharmaceutical Sciences have published 1.5k papers, which have received a total of 74.2k indexed citations . Scholars at this organization have produced 331 papers in Oncology, 56 papers in Pharmaceutical Science, 629 papers in Molecular Biology, 146 papers in Cellular and Molecular Neuroscience and 42 papers in Immunology and Allergy on the topics of Lymphatic System and Diseases (160 papers), Monoclonal and Polyclonal Antibodies Research (116 papers), RNA Interference and Gene Delivery (101 papers), Neuroscience and Neuropharmacology Research (80 papers), Immunotherapy and Immune Responses (68 papers), Angiogenesis and VEGF in Cancer (68 papers), Chemical Synthesis and Analysis (65 papers) and Advanced biosensing and bioanalysis techniques (56 papers). Their work is cited by papers focused on Biomaterials (7.3k citations), Oncology (13.2k citations), Pharmaceutical Science (3.2k citations), Molecular Biology (29.9k citations) and Immunology (7.1k citations). Authors at Institute of Pharmaceutical Sciences collaborate with scholars in Switzerland, Germany and United States and have published in prestigious journals including Journal of Controlled Release, PLoS ONE, Scientific Reports, Chemistry - A European Journal and CHIMIA International Journal for Chemistry. Some of Institute of Pharmaceutical Sciences's most productive authors include Michael J. Detmar, Dario Neri, Jean‐Christophe Leroux, Hans Peter Merkle, Bruno A. Gander, Gisbert Schneider, Hanns Ulrich Zeilhofer, Karl-Heinz Altmann, Claudiu Trandafir Supuran and Lorenz Meinel.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact